Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Join Ads Marketplace to earn through podcast sponsorships.
Manage your ads with dynamic ad insertion capability.
Monetize with Apple Podcasts Subscriptions via Podbean.
Earn rewards and recurring income from Fan Club membership.
Get the answers and support you need.
Resources and guides to launch, grow, and monetize podcast.
Stay updated with the latest podcasting tips and trends.
Check out our newest and recently released features!
Podcast interviews, best practices, and helpful tips.
The step-by-step guide to start your own podcast.
Create the best live podcast and engage your audience.
Tips on making the decision to monetize your podcast.
The best ways to get more eyes and ears on your podcast.
Everything you need to know about podcast advertising.
The ultimate guide to recording a podcast on your phone.
Steps to set up and use group recording in the Podbean app.
Chemo-Führerschein GYNÄKOLOGIE
Education
Was ändert sich in der Therapie des frühen Mammakarzinoms nach dem ASCO-Kongress 2023?
Wir haben für Sie drei Highlights ausgesucht:
1. NATALEE: CDK4/6-Inhibitor Ribociclib in der adjuvanten Therapie des HR+ HER2- Mammakarzinoms
2. Tarantino et al.: Große retrospektive Analyse zu kleinen (T1 N0) triple-negativen Mammakarzinomen: brauchen sie immer eine Chemotherapie?
3. Short-HER: Kürzere Dauer der Anti-HER2-Therapie mit Trastuzumab beim frühen HER2-positiven Mammakarzinom
Viel Spaß beim Hören!
Nicht vergessen: am 24.06.23 findet der nächste Online-Kurs statt! Natürlich mit On demand Version, die Ihnen für 3 Monate zur Verfügung steht. Anmeldung unter: www.chemo-fuehrerschein.de
Neue AGO-Leitlinie 2025: Metastasiertes Mammakarzinom
Neue AGO-Leitlinie 2025: Frühes Mammakarzinom
Neues vom San Antonio-Kongress 2024
Post-ESMO 2024
Herausforderung orale Therapien
Post-ASCO 2024
Endokrine Therapie des Mammakarzinoms
Neue AGO-Empfehlungen 2024
Die "Basics"
Post San Antonio 2023
Post-ESMO 2023
Neoadjuvante Therapie des Mammakarzinoms
Post-neoadjuvante Therapie des Mammakarzinoms
Post-ASCO: Metastasiertes Mammakarzinom
Post-ASCO: Gyn-Onko
BRCA-Status: für welche Patientin wichtig?
HER2 low - was muss ich wissen?
Create your
podcast in
minutes
It is Free
The Pacific War - week by week
German Stories - Learn German with Stories | Deutsch lernen mit Geschichten
Bestbookbits
The Mel Robbins Podcast
The Jordan B. Peterson Podcast